STERIS to acquire Cantel Medical for $4.6 billion

STERIS plc has signed a definitive agreement to acquire Cantel Medical Corp in a cash and stock transaction valued at $84.66 per share, representing a total enterprise value of approximately $4.6 billion. The deal is expected to be accretive to adjusted earnings per diluted share in year one.

“We have long appreciated Cantel, which is a natural complement and extension to STERIS’s product and service offerings, global reach and Customers.”sterisplc.gcs-web.com

• 1 source
• sterisplc.gcs-web.comSTERIS Announces Definitive Agreement to Acquire Cantel Medical | STERIS plcJan 12, 2021

Summarized from public sources; check the original articles before acting on it.